Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

• Status: Completed
• Trial end date: 2008-04-01

Summary

RATIONALE: Chemotherapy may cause early menopause in premenopausal women. Triptorelin may prevent this from happening.

PURPOSE: This randomized phase III trial is studying triptorelin to see how well it works in preventing early menopause in premenopausal women who are receiving chemotherapy for stage I, stage II, or stage III breast cancer that has been removed by surgery.

• Phase: Phase 3

Details

• Lead Sponsor: Gruppo Italiano Mammella (GIM)
• Treatments: Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fluorouracil; Liposomal doxorubicin; Methotrexate; Paclitaxel; Triptorelin Pamoate